Pharma Reviews: Biocon Says Won't Play The Bloodbath Game In Indian Market For Now

Biocon Ltd.—India's second-best performing pharmaceutical stock this year—will continue to focus on Europe and the U.S. in 2019. That's according ...
Read more: Biocon Says Won't Play The Bloodbath Game In Indian Market For Now